ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
- Resource Type
- Article
- Authors
- Kogure, Yasunori; Handa, Hiroshi; Ito, Yuta; Ri, Masaki; Horigome, Yuichi; Iino, Masaki; Harazaki, Yoriko; Kobayashi, Takahiro; Abe, Masahiro; Ishida, Tadao; Ito, Shigeki; Iwasaki, Hiromi; Kuroda, Junya; Shibayama, Hirohiko; Sunami, Kazutaka; Takamatsu, Hiroyuki; Tamura, Hideto; Hayashi, Toshiaki; Akagi, Kiwamu; Shinozaki, Tomohiro; Yoshida, Takahiro; Mori, Ikuo; Iida, Shinsuke; Maeda, Takahiro; Kataoka, Keisuke
- Source
- In Blood 6 June 2024 143(23):2401-2413
- Subject
- Free Research Articles
Lymphoid Neoplasia
Multiple Myeloma
- Language
- ISSN
- 0006-4971